Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry.

Autor: Viktoria Papp, Mathias Due Buron, Volkert Siersma, Peter Vestergaard Rasmussen, Zsolt Illes, Matthias Kant, Claudia Hilt, Zsolt Mezei, Homayoun Roshanisefat, Tobias Sejbæk, Arkadiusz Weglewski, Janneke van Wingerden, Svend Sparre Geertsen, Stephan Bramow, Finn Sellebjerg, Melinda Magyari

Publikováno v: PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)

ObjectiveTeriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enrolle

Externí odkaz: https://doaj.org/article/4c38c13ec9ce425b87933408ba9724f9

Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry

Autor: Zsolt Illes, Stephan Bramow, Volkert Siersma, Tobias Sejbaek, Homayoun Roshanisefat, Mathias Buron, Arkadiusz Weglewski, Viktoria Papp, Melinda Magyari, Zsolt Mezei, Svend Sparre Geertsen, Finn Sellebjerg, Janneke van Wingerden, Peter Vestergaard Rasmussen, Matthias Kant, Claudia Hilt

Publikováno v: Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, Van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in the Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbaek, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLoS ONE, vol. 16, no. 5, 0250820 . https://doi.org/10.1371/journal.pone.0250820
PLoS ONE
Papp, V, Buron, M D, Siersma, V, Rasmussen, P V, Illes, Z, Kant, M, Hilt, C, Mezei, Z, Roshanisefat, H, Sejbæk, T, Weglewski, A, van Wingerden, J, Geertsen, S S, Bramow, S, Sellebjerg, F & Magyari, M 2021, ' Real-world outcomes for a complete nationwide cohort of more than 3200 teriflunomide-treated multiple sclerosis patients in The Danish Multiple Sclerosis Registry ', PLOS ONE, vol. 16, no. 5, e0250820 . https://doi.org/10.1371/journal.pone.0250820

Objective Teriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enroll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a475a534c4fb6343b177993f437df9c
https://vbn.aau.dk/da/publications/14313629-8b97-4183-84c4-d23d820c03f8

Worldwide incidence and prevalence of NMO: A systematic review

Autor: Maria Sepúlveda, Zsolt Illes, Jacqueline Palace, Orhan Aktas, Philippe Cabre, Jun Ichi Kira, Romain Marignier, Maria Isabel Leite, Viktoria Papp, Melinda Magyari, Simon Broadley, Anu Jacob, Olafur Sveinsson, Albert Saiz, Thomas Berger, Katsuichi Miyamoto

Publikováno v: Neurology.

Objective:Since the last epidemiological review of NMO/NMOSD, 22 additional studies have been conducted. We systematically review the worldwide prevalence, incidence and basic demographic characteristics of NMOSD, and provide a critical overview of s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dbbaf7cb604207556dfb95e235a4147c
https://doi.org/10.1212/wnl.0000000000011153

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review

Autor: Viktoria, Papp, Melinda, Magyari, Orhan, Aktas, Thomas, Berger, Simon A, Broadley, Philippe, Cabre, Anu, Jacob, Jun-Ichi, Kira, Maria Isabel, Leite, Romain, Marignier, Katsuichi, Miyamoto, Jacqueline, Palace, Albert, Saiz, Maria, Sepulveda, Olafur, Sveinsson, Zsolt, Illes

Publikováno v: Neurology
article-version (Version of Record) 3

Objective Since the last epidemiologic review of neuromyelitis optica/neuromyelitis optica spectrum disorder (NMO/NMOSD), 22 additional studies have been conducted. We systematically review the worldwide prevalence, incidence, and basic demographic c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::32bdeed5781489052f76922653544f90
https://pubmed.ncbi.nlm.nih.gov/33310876

A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary

Autor: László Horváth, Gabriella Molnár, Péter Ács, Viktoria Papp, Judit Kasza, Zsolt Illes, László Vécsei, Adrienne Jóri Birkás, Csilla Rozsa, Gábor Lovas, Thor Petersen, Levente Kerényi, István Deme, Mária Sátori, Gábor Jakab, Zsuzsanna Lohner, Krisztina Bencsik, Piroska Imre, Melinda Magyari, Gyöngyi Galántai, Gábor Rum, Ágnes Köves, Ferenc Nagy, Krisztina Kovacs, Cecilia Rajda, Magdolna Simó, Anna Iljicsov, Zsuzsanna Nagy, Zita Jobbágy, Péter Diószeghy, Timea Berki, Nils Koch-Henriksen, Sámuel Komoly

Publikováno v: Papp, V, Iljicsov, A, Rajda, C, Magyari, M, Koch-Henriksen, N, Petersen, T, Jakab, G, Deme, I, Nagy, F, Imre, P, Lohner, Z, Kovács, K, Birkás, A J, Köves, Rum, G, Nagy, Z, Kerényi, L, Vécsei, L, Bencsik, K, Jobbágy, Z, Diószeghy, P, Horváth, L, Galántai, G, Kasza, J, Molnár, G, Simó, M, Sátori, M, Rózsa, C, Ács, P, Berki, T, Lovas, G, Komoly, S & Illes, Z 2020, ' A population-based epidemiological study of neuromyelitis optica spectrum disorder in Hungary ', European Journal of Neurology, vol. 27, no. 2, pp. 308-317 . https://doi.org/10.1111/ene.14079

Background and purpose: The goal of this study was to determine the prevalence and incidence of neuromyelitis optica spectrum disorder (NMOSD) in Hungary based on the 2015 International Panel of NMO Diagnosis (IPND) criteria. Methods: A retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec270552c6eb5b7401fc8e643712fba9
https://pure.au.dk/portal/da/publications/a-populationbased-epidemiological-study-of-neuromyelitis-optica-spectrum-disorder-in-hungary(b01946d5-1cef-43d4-b137-26dc5f3fc844).html